SCHEMBL7716044

SCHEMBL7716044

Cc1cccc(N(c2ccccc2)c2ccc(/C=C/c3ccc(/C=C/c4ccc(N(c5ccccc5)c5cccc(C)c5)cc4)cc3)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RELA Q04206 2/20 0.48
APP P05067 2/20 0.44
CTDSP1 Q9GZU7 1/20 0.42
TRPM8 Q7Z2W7 2/20 0.41
NFE2L2 Q16236 1/20 0.40
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CASP3 P42574 2/20 0.39
SENP8 Q96LD8 2/20 0.39
SENP7 Q9BQF6 2/20 0.39
SENP6 Q9GZR1 2/20 0.39
EGFR P00533 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10128949 1.00 RELA (0.48) RELAAPPCTDSP1TRPM8NFE2L2
SCHEMBL7717148 1.00 RELA (0.48) RELAAPPCTDSP1TRPM8NFE2L2
SCHEMBL13372121 1.00 RELA (0.48) RELAAPPCTDSP1TRPM8NFE2L2
SCHEMBL13358324 1.00 RELA (0.48) RELAAPPCTDSP1TRPM8NFE2L2
SCHEMBL13358227 1.00 RELA (0.48) RELAAPPCTDSP1TRPM8NFE2L2
SCHEMBL5489258 0.98 RELA (0.52) RELAAPPCTDSP1TRPM8NFE2L2
SCHEMBL5489261 0.98 RELA (0.52) RELAAPPCTDSP1TRPM8NFE2L2
SCHEMBL17084643 0.98 RELA (0.52) RELAAPPCTDSP1TRPM8NFE2L2
SCHEMBL13136848 0.98 RELA (0.52) RELAAPPCTDSP1TRPM8NFE2L2
SCHEMBL13358249 0.97 TRPM8 (0.46) RELAAPPCTDSP1TRPM8NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8197722-B2 Irradiating the compound (containing two electron donor groups and a bridge of pi-conjugated bonds containing electron donor groups) with light, and the compound is converted to a multi-photon electronically excited state THE CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2012-06-12 US disclosed
US-8197722-B2 Irradiating the compound (containing two electron donor groups and a bridge of pi-conjugated bonds containing electron donor groups) with light, and the compound is converted to a multi-photon electronically excited state THE CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2012-06-12 US disclosed
US-8197722-B2 Irradiating the compound (containing two electron donor groups and a bridge of pi-conjugated bonds containing electron donor groups) with light, and the compound is converted to a multi-photon electronically excited state THE CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2012-06-12 US disclosed
US-7790353-B2 Multidirectional photoreactive absorption method 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-09-07 US disclosed
US-7790347-B2 Multi-photon reacted articles with inorganic particles and method for fabricating structures 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-09-07 US disclosed
US-7790347-B2 Multi-photon reacted articles with inorganic particles and method for fabricating structures 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-09-07 US disclosed
US-7790353-B2 Multidirectional photoreactive absorption method 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-09-07 US disclosed
US-20100207078-A1 DEPROTECTION OF FUNCTIONAL GROUPS BY MULTI-PHOTON INDUCED ELECTRON TRANSFER THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA 2010-08-19 US disclosed
US-20100207078-A1 DEPROTECTION OF FUNCTIONAL GROUPS BY MULTI-PHOTON INDUCED ELECTRON TRANSFER THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA 2010-08-19 US disclosed
US-7655376-B2 Multibeam interference; pyrolysis; chemical vapor deposition 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-02-02 US disclosed
US-20070264501-A1 MULTI-PHOTON REACTIVE COMPOSITIONS WITH INORGANIC PARTICLES AND METHOD FOR FABRICATING STRUCTURES 3M INNOVATIVE PROPERTIES COMPANY 2007-11-15 US disclosed
US-20070264501-A1 MULTI-PHOTON REACTIVE COMPOSITIONS WITH INORGANIC PARTICLES AND METHOD FOR FABRICATING STRUCTURES 3M INNOVATIVE PROPERTIES COMPANY 2007-11-15 US disclosed
US-7265161-B2 Multi-photon reactive compositions with inorganic particles and method for fabricating structures 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-09-04 US disclosed
US-7265161-B2 Multi-photon reactive compositions with inorganic particles and method for fabricating structures 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-09-04 US disclosed
US-20070087284-A1 MULTIPASS MULTIPHOTON ABSORPTION METHOD AND APPARATUS 3M INNOVATIVE PROPERTIES COMPANY 2007-04-19 US disclosed
US-20070087284-A1 MULTIPASS MULTIPHOTON ABSORPTION METHOD AND APPARATUS 3M INNOVATIVE PROPERTIES COMPANY 2007-04-19 US disclosed
US-7166409-B2 Multipass multiphoton absorption method and apparatus 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-01-23 US disclosed
US-7166409-B2 Multipass multiphoton absorption method and apparatus 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-01-23 US disclosed
US-20020185634-A1 Two-photon or higher-order absorbing optical materials and methods of use CALIFORNIA INSTITUTE OF TECHNOLOGY 2002-12-12 US disclosed
US-6267913-B1 IN HOLOGRAPHYL, BIOLOGY, OPTICAL DATA STORAGE CALIFORNIA INSTITUTE OF TECHNOLOGY 2001-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100207078-A1 DEPROTECTION OF FUNCTIONAL GROUPS BY MULTI-PHOTON INDUCED ELECTRON TRANSFER GPX4, ERCC4, CYBA RELA 1414/4885APP 2910/4885CTDSP1 1797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.